We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
- Authors
Ramsay, L E; Williams, B; Johnston, G D; MacGregor, G A; Poston, L; Potter, J F; Poulter, N R; Russell, G
- Abstract
• Use non-pharmacological measures in all hypertensive and borderline hypertensive people. • Initiate antihypertensive drug therapy in people with sustained systolic blood pressures (BP) &ges;160 mm Hg or sustained diastolic BP &ges;100 mm Hg. • Decide on treatment in people with sustained systolic BP between 140 and 159 mm Hg or sustained diastolic BP between 90 and 99 mm Hg according to the presence or absence of target organ damage, cardiovascular disease or a 10-year coronary heart disease (CHD) risk of &ges;15% according to the Joint British Societies CHD risk assessment programme/risk chart. • In people with diabetes mellitus, initiate antihypertensive drug therapy if systolic BP is sustained &ges;140 mm Hg or diastolic BP is sustained &ges;90 mm Hg. • In non-diabetic hypertensive people, optimal BP treatment targets are: systolic BP <140 mm Hg and diastolic BP <85 mm Hg. The minimum acceptable level of control (Audit Standard) recommended is <150/<90 mm Hg. Despite best practice, these levels will be difficult to achieve in some hypertensive people. • In diabetic hypertensive people, optimal BP targets are; systolic BP <140 mm Hg and diastolic BP <80 mm Hg. The minimum acceptable level of control (Audit Standard) recommended is <140/<90 mm Hg. Despite best practice, these levels will be difficult to achieve in some people with diabetes and hypertension. • In the absence of contraindications or compelling indications for other antihypertensive agents, low dose thiazide diuretics or beta-blockers are preferred as first-line therapy for the majority of hypertensive people. In the absence of compelling indications for beta-blockade, diuretics or long acting dihydropyridine calcium antagonists are preferred to beta-blockers in older subjects. Compelling indications and contra-indications for all antihypertensive drug classes are specified. • For most hypertensives, a combination of antihypertensive drugs will be...
- Subjects
UNITED Kingdom; HYPERTENSION; SOCIETIES
- Publication
Journal of Human Hypertension, 1999, Vol 13, Issue 9, p569
- ISSN
0950-9240
- Publication type
Article